Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Analytical Chemistry|February 18, 2026
The First NIR Fluorescent Probe for Bioimaging of Cystathionine-γ-lyase Activity in Living Cells and Xenograft Tumor ModelsChangyu Zhang, Yuanmeng Liu, Weizhu Wu, et al.
Frontiers in Oncology|June 13, 2022
"Elastic Stretch Cavity Building" System in Endoscopic Thyroidectomy of Giant Thyroid TumorsGaoxiang Chen, Hai Zhang, Cheng Li, et al.
Cancer Cell International|October 2, 2020
SOX4 promotes the growth and metastasis of breast cancerJing Zhang, Chunhua Xiao, Zhenbo Feng, et al.
Frontiers in Oncology|January 2, 2023
An autophagy-related long non-coding RNA prognostic model and related immune research for female breast cancerJiafeng Chen, Xinrong Li, Shuixin Yan, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|June 27, 2025
PTf-SRiApt Targeting SCAF4-POLR2A Interaction Suppresses Tumor Growth and Promotes Antitumor Immunity in Triple-Negative Breast CancerLiyan Fei, Yichun Pan, Jie Zhai, et al.
Elife|April 3, 2025
Pyrotinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (PERSIST): A multicenter phase II trialFeilin Cao, Zhaosheng Ma, Zenggui Wu, et al.
Health and Quality of Life Outcomes|March 25, 2016
Health-related quality of life of postmenopausal Chinese women with hormone receptor-positive early breast cancer during treatment with adjuvant aromatase inhibitors: a prospective, multicenter, non-interventional studyAyong Cao, Jin Zhang, Xiaoan Liu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 9, 2025
Adjuvant Epirubicin Plus Cyclophosphamide Followed by Taxanes With or Without Carboplatin in Early-Stage Triple-Negative Breast Cancer (RJBC 1501): A Randomized Phase III TrialXiaosong Chen, Jiahui Huang, Haoting Shi, et al.
Cancer|August 2, 2024
Clinical best practices in interdisciplinary management of human epidermal growth factor receptor 2 antibody-drug conjugates-induced interstitial lung disease/pneumonitis: An expert consensus in ChinaChunwei Xu, Zhanhong Chen, Yuanli Xia, et al.
Pageof 4